The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(2-(((3'-(Aminomethyl)-[1,1'-biphenyl]-3-yl)oxy)methyl)phenyl)acetic Acid ID: ALA4473278
PubChem CID: 117819978
Max Phase: Preclinical
Molecular Formula: C22H21NO3
Molecular Weight: 347.41
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: NCc1cccc(-c2cccc(OCc3ccccc3CC(=O)O)c2)c1
Standard InChI: InChI=1S/C22H21NO3/c23-14-16-5-3-8-17(11-16)18-9-4-10-21(12-18)26-15-20-7-2-1-6-19(20)13-22(24)25/h1-12H,13-15,23H2,(H,24,25)
Standard InChI Key: OPJHZSZMYGOFEH-UHFFFAOYSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
2.2146 -23.0926 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2107 -23.9101 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9183 -24.3175 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6263 -23.9077 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6224 -23.0863 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9143 -22.6826 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9213 -25.1304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2125 -25.5392 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2130 -26.3556 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9217 -26.7642 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6313 -26.3505 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6273 -25.5354 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5056 -26.7646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5061 -27.5818 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
4.3280 -22.6741 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.0378 -23.0791 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7434 -22.6668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4514 -23.0768 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1566 -22.6652 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1528 -21.8472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4381 -21.4424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7359 -21.8563 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.4529 -23.8940 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1613 -24.3013 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1627 -25.1185 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.8683 -23.8915 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
3 7 1 0
9 13 1 0
13 14 1 0
5 15 1 0
15 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
18 23 1 0
23 24 1 0
24 25 2 0
24 26 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 347.41Molecular Weight (Monoisotopic): 347.1521AlogP: 4.02#Rotatable Bonds: 7Polar Surface Area: 72.55Molecular Species: ZWITTERIONHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.01CX Basic pKa: 9.24CX LogP: 1.69CX LogD: 1.68Aromatic Rings: 3Heavy Atoms: 26QED Weighted: 0.68Np Likeness Score: -0.35
References 1. Karki RG, Powers J, Mainolfi N, Anderson K, Belanger DB, Liu D, Ji N, Jendza K, Gelin CF, Mac Sweeney A, Solovay C, Delgado O, Crowley M, Liao SM, Argikar UA, Flohr S, La Bonte LR, Lorthiois EL, Vulpetti A, Brown A, Long D, Prentiss M, Gradoux N, de Erkenez A, Cumin F, Adams C, Jaffee B, Mogi M.. (2019) Design, Synthesis, and Preclinical Characterization of Selective Factor D Inhibitors Targeting the Alternative Complement Pathway., 62 (9): [PMID:30995036 ] [10.1021/acs.jmedchem.9b00271 ]